Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo

By Li Wei   Wang Jie   Jiang Hong-Ru   Xu Xiao-Li   Zhang Jun   Liu Mei-Lin   Zhai Ling-Yun  

International Journal of Molecular Sciences, Vol. 12, Iss. 1, 2011-01 ,pp. : 668-681

MDPI

Access to resources Recommend Favorite

Antiplatelet Effect and Selective Binding to Cyclooxygenase (COX) by Molecular Docking Analysis of Flavonoids and Lignans

By Wu Chien-Ming   Wu Shu-Chun   Chung Wan-Jung   Lin Hsien-Cheng   Chen Kun-Tze   Chen Yu-Chian   Hsu Mei-Feng   Yang Jwu-Maw   Wang Jih-Pyang   Lin Chun-Nan  

International Journal of Molecular Sciences, Vol. 8, Iss. 8, 2007-08 ,pp. : 830-841

MDPI

Access to resources Recommend Favorite

Role of mTOR Inhibitors in Kidney Disease

By Kajiwara Moto   Masuda Satohiro  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 975-975

MDPI

Access to resources Recommend Favorite

Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study

By Hensley Abigail   Beales Ian L. P.  

Pharmaceuticals, Vol. 8, Iss. 3, 2015-09 ,pp. : 512-524

MDPI

Access to resources Recommend Favorite

Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma

By Li Wei   Cai Jia-Hui   Zhang Jun   Tang Yun-Xian   Wan Liang  

International Journal of Molecular Sciences, Vol. 13, Iss. 8, 2012-08 ,pp. : 9741-9753

MDPI

Access to resources Recommend Favorite